Creative Life Science Co (ROCO:7837) ROC (Joel Greenblatt) %: 33.30% (As of Dec. 2025) — 16% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7837 Creative Life Science Co Ltd ROCO:7837
19 GF Score
Price NT$72.10
! 3 Warning Signs
View Full Analysis

What is Creative Life Science Co ROC (Joel Greenblatt) %?

Creative Life Science Co ROCO:7837 +1.55% 19 ROC (Joel Greenblatt) % is 33.30% as of Dec. 2025, which is 16% above its 10-year median of 28.61. GuruFocus rates ROCO:7837 with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 1,324 Biotechnology companies, Creative Life Science Co ranks better than 88.6% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Creative Life Science Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 33.30%.

The historical rank and industry rank for Creative Life Science Co's ROC (Joel Greenblatt) % or its related term are showing as below:

ROCO:7837' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 26.09   Med: 28.61   Max: 88.52
Current: 27.25

During the past 5 years, Creative Life Science Co's highest ROC (Joel Greenblatt) % was 88.52%. The lowest was 26.09%. And the median was 28.61%.

ROCO:7837's ROC (Joel Greenblatt) % is ranked better than
88.6% of 1324 companies
in the Biotechnology industry
Industry Median: -306.72 vs ROCO:7837: 27.25

Creative Life Science Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Creative Life Science Co  (ROCO:7837) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Creative Life Science Co ROC (Joel Greenblatt) % Related Terms


Creative Life Science Co ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Creative Life Science Co's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Life Science Co ROC (Joel Greenblatt) % Chart

Creative Life Science Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
0.00 88.52 28.58 28.63 26.09

Creative Life Science Co Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial 0.00 28.36 28.83 21.99 33.30

ROCO:7837 vs VRTX, REGN, RVMD: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, Creative Life Science Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Life Science Co ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Life Science Co's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Creative Life Science Co's ROC (Joel Greenblatt) % falls into.


ROCO:7837
19GF Score
Creative Life Science Co Ltd ROCO:7837
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creative Life Science Co ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(175.562 + 112.993 + 13.904) - (200.871 + 0 + 133.84)
=-32.252

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(186.891 + 116.556 + 13.434) - (224.935 + 0 + 134.032)
=-42.086

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Creative Life Science Co for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=175.206/( ( (470.976 + max(-32.252, 0)) + (581.219 + max(-42.086, 0)) )/ 2 )
=175.206/( ( 470.976 + 581.219 )/ 2 )
=175.206/526.0975
=33.30 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 33.30% mean?
Creative Life Science Co (ROCO:7837) has a ROC (Joel Greenblatt) % of 33.30% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Creative Life Science Co and its competitors. This is 16% above median its historical median of 28.61. Over the past decade, Creative Life Science Co's ROC (Joel Greenblatt) % has ranged from 26.09 to 88.52. According to the industry distribution chart, Creative Life Science Co ranks #151 out of 1324 companies in the Biotechnology industry, placing it in the top 11.4%.
Is Creative Life Science Co's ROC (Joel Greenblatt) % too high?
Creative Life Science Co's current ROC (Joel Greenblatt) % of 33.30% is 16% above median its 10-year median of 28.61. Over the past 10 years, this metric has ranged from a low of 26.09 to a high of 88.52. Based on the distribution chart, Creative Life Science Co ranks #151 out of 1324 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Creative Life Science Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's ROC (Joel Greenblatt) % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Creative Life Science Co ranks #151 out of 1324 companies for ROC (Joel Greenblatt) %. This places Creative Life Science Co in the top 11% of its industry — outperforming the majority of peers. Historically, Creative Life Science Co's own ROC (Joel Greenblatt) % has ranged from 26.09 to 88.52 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Creative Life Science Co and its competitors. Creative Life Science Co's current ROC (Joel Greenblatt) % is 33.30%, which is 16% above median its own 10-year median of 28.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current ROC (Joel Greenblatt) % of 33.30%. The current ROC (Joel Greenblatt) % is 33.30%, which is 16% above median its 10-year median of 28.61. Creative Life Science Co's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current ROC (Joel Greenblatt) % is 33.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Creative Life Science Co Business Description

Address Wuquan 3rd Road, No. 24, Wugu District, New Taipei City, TWN, 248021
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
19GF Score

Get the complete analysis for ROCO:7837

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$72.10
Price